[ XXXX : a @entity3761 -sensitive dermatosis].

@entity1 @entity3761 @entity5477 @entity1751 @entity4878 @entity6794 @entity14086 @entity102
@entity1751 is a @entity102 with a major impact on the quality of life. Therapeutic options were long restricted to local disinfectants and systemic antibiotics, as well as repeated incision and drainage which produce only short term benefits. @entity4878 , antiandrogens and radiation therapy are only partially successful. The best approach appears to be surgical removal of the entire apocrine sweat gland apparatus. @entity3761 is used in dermatology to treat inflammatory dermatoses such as @entity14086 and @entity6794 , and was formerly the treatment of choice for @entity5477 . We report its successful use in @entity1751 . Five female @entity1 aged 23-40 years with @entity1751 for a mean of 9.6 years were included. All @entity1 showed an almost complete resolution of their symptoms within 2-4 weeks. All @entity1 rated the treatment results with @entity3761 as good or very good. The treatment was well tolerated and no important side effects occurred. Because of its lack of teratogenicity, @entity3761 may be the most favorable treatment option in young @entity1 with @entity1751 .
